InnoSIGN

Recent Finacing

Series A

Recent Raise

$8M

InnoSIGN commercializes OncoSIGNal mRNA assays measuring pathway activity in tumors and immune cells to predict drug response, offering a qPCR 7-pathway RUO test with cloud analysis and >100k-profile database.

Founded 2020

Noord-Brabant, The Netherlands

11-50

Private

innosignbio.com

Highlights

Focus Areas

Biotechnology

Life Science

Medical

Precision Medicine

Recent Investors

Financials

$8M

Total Raised

1

Funding round

4

Investors

Team

Upgrade to view the team

See the team members at InnoSIGN.